ProQR Therapeutics NV
NASDAQ:PRQR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ProQR Therapeutics NV
NASDAQ:PRQR
|
NL |
|
N
|
Nov Inc
F:NO8
|
US |
|
M
|
Metals Australia Ltd
ASX:MLS
|
AU |
|
S
|
Sakura Development Co Ltd
TWSE:2539
|
TW |
|
H
|
Halmont Properties Corp
XTSX:HMT
|
CA |
|
Atlantic Navigation Holdings (Singapore) Ltd
SGX:5UL
|
SG |
|
Odakyu Electric Railway Co Ltd
OTC:ODERF
|
JP |
|
Yancoal Australia Ltd
ASX:YAL
|
AU |
|
Essity AB (publ)
F:ESW
|
SE |
|
N
|
Neorigin Co Ltd
KOSDAQ:094860
|
KR |
|
Biorem Inc
XTSX:BRM
|
CA |
Intrinsic Value
Is PRQR undervalued or overvalued?
See the intrinsic value estimate for ProQR Therapeutics NV and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
PRQR looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with PRQR’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What ProQR Therapeutics Does
ProQR Therapeutics is a biotech company that designs RNA-based medicines for people with rare genetic diseases. Instead of making traditional small-molecule drugs or antibodies, it works on therapies that try to correct problems caused by faulty genes at the RNA level, which is the step between DNA and protein production. Its main work is in developing treatments that can help cells make the right protein again.
- Headquarters
- Netherlands NL
- Employees
- 187
- IPO date
- Sep 18, 2014
Revenue & Expenses Breakdown
ProQR Therapeutics NV
Earnings Waterfall
ProQR Therapeutics NV
The intrinsic value for ProQR Therapeutics NV (PRQR) under the Base Case is hidden USD.
Compared with the current market price of 1.33 USD, the stock appears hidden.